Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cardioprotection of Silymarin for Patients Received Anthracycline Chemotherapy

NCT04434404 is registered in ClinicalTrials.gov with Horus University as lead sponsor.

NCT NCT04434404
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04434404 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cardioprotection of Silymarin for Patients Received Anthracycline Chemotherapy
Lead sponsor
Horus University
Phase
Phase 4
Overall status
Completed
Start date
September 10, 2018
Completion date
December 10, 2019
Enrollment
83 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer